Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03502811 · ClinicalTrials.gov registry record
The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices
A clinical trial of Mitral Regurgitation and Mitral Valve Regurgitation, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 1,041
- Enrollment target
- 20
- Study locations
NCT03502811 is a study of Mitral Regurgitation and Mitral Valve Regurgitation that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,041 participants, roughly in line with the 984-participant average among 26 other Mitral Regurgitation trials with a reported enrollment target. The trial reports 20 study locations across 16 states.
The verdict
NCT03502811, a study of Mitral Regurgitation and Mitral Valve Regurgitation, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 1,041 participants
- Enrollment target
- 20
- Study locations
Study Summary
The MitraClip EXPAND Study (A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of MitraClip Devices) is designed to confirm the safety and performance of the MitraClip NTR System and MitraClip XTR System.
Conditions Studied
Interventions
- DEVICE MitraClip NTR/XTR System
Study Locations (20)
California
- Scripps Health - La Jolla
- Cedars-Sinai Medical Center - Los Angeles
- University of California - Davis Medical Center - Sacramento
New York
- New York-Presbyterian/Columbia University Medical Center - New York
- Mount Sinai Hospital - New York
- New York University Hospital - New York
Alabama
- Baptist Medical Center Princeton - Birmingham
Arizona
- Phoenix Cardiovascular Research Group - Phoenix
Colorado
- University of Colorado Hospital - Aurora
Florida
- JFK Medical Center - West Palm Beach
Illinois
- Northwestern Memorial Hospital - Chicago
Kansas
- Via Christi Regional Medical Center - St. Francis Campus - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,041 participants |
| Start Date | 2018-04-26 |
| Est. Completion | 2020-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03502811
The ClinicalTrials.gov registry entry for NCT03502811 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,041 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 984-participant average among 26 other Mitral Regurgitation trials with a reported enrollment target. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Mitral Regurgitation appearing as the primary indexed condition, and to 1 intervention - of which MitraClip NTR/XTR System is the first listed.
NCT03502811 reports 20 study locations spanning 16 distinct geographic areas - top geographies include California, New York, Alabama.
Frequently Asked Questions
What is clinical trial NCT03502811 about?
NCT03502811 is a clinical study titled "The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices". The MitraClip EXPAND Study (A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of MitraClip Devices) is designed to confirm the safety and performance of the MitraClip NTR System and MitraClip XTR System.
What is the current status of trial NCT03502811?
This trial is currently completed. The enrollment target is 1,041 participants. The study started on 2018-04-26. Estimated completion is 2020-12-31.
What conditions does trial NCT03502811 study?
This clinical trial studies the following conditions: Mitral Regurgitation, Mitral Valve Regurgitation.
What interventions are being tested in trial NCT03502811?
The interventions under investigation include: MitraClip NTR/XTR System (DEVICE).
Who is sponsoring clinical trial NCT03502811?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03502811 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mitral Regurgitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System
RECRUITING · NA
-
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
RECRUITING · NA
-
EFS of the CardioMech MVRS
RECRUITING · NA
-
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
RECRUITING
-
Novel Characterization of Sex Specific Biologic Signatures in Valvular Heart Disease
RECRUITING
-
In Search of Best Practices for Patients With Heart Failure and Secondary Mitral Regurgitation: An Evaluation of the Inova Heart Failure Treatment Algorithm
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.